5F-CUMYL-P7AICA (also known as CUMYL-5F-P7AICA or SGT-263) is a pyrrolo[2,3-b]pyridine-3-carboxamide based synthetic cannabinoid that has been sold as a designer drug.

[1][2][3][4][5][6] It was first identified by the EMCDDA in February 2015.

[7]

This cannabinoid related article is a stub.

You can help Wikipedia by expanding it.